ATE128865T1 - Verwendung von l-deprenyl zur herstellung eines arzneimittels zur behandlung der cushing's- krankheit. - Google Patents

Verwendung von l-deprenyl zur herstellung eines arzneimittels zur behandlung der cushing's- krankheit.

Info

Publication number
ATE128865T1
ATE128865T1 AT93300476T AT93300476T ATE128865T1 AT E128865 T1 ATE128865 T1 AT E128865T1 AT 93300476 T AT93300476 T AT 93300476T AT 93300476 T AT93300476 T AT 93300476T AT E128865 T1 ATE128865 T1 AT E128865T1
Authority
AT
Austria
Prior art keywords
deprenyl
disease
cushing
treatment
production
Prior art date
Application number
AT93300476T
Other languages
English (en)
Inventor
William Woodrow Ruehl
David Stewart Bruyette
David Stevens
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Application granted granted Critical
Publication of ATE128865T1 publication Critical patent/ATE128865T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93300476T 1992-03-27 1993-01-22 Verwendung von l-deprenyl zur herstellung eines arzneimittels zur behandlung der cushing's- krankheit. ATE128865T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/858,702 US5192808A (en) 1990-08-31 1992-03-27 Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)

Publications (1)

Publication Number Publication Date
ATE128865T1 true ATE128865T1 (de) 1995-10-15

Family

ID=25328952

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93300476T ATE128865T1 (de) 1992-03-27 1993-01-22 Verwendung von l-deprenyl zur herstellung eines arzneimittels zur behandlung der cushing's- krankheit.

Country Status (7)

Country Link
US (1) US5192808A (de)
EP (1) EP0562705B1 (de)
AT (1) ATE128865T1 (de)
DE (1) DE69300608T2 (de)
DK (1) DK0562705T3 (de)
ES (1) ES2082587T3 (de)
GR (1) GR3018657T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
US5565495A (en) * 1990-08-31 1996-10-15 Deprenyl Animal Health, Inc. Method for survival curve shifting in dogs
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
EP0623344B1 (de) * 1993-05-04 2000-07-26 Ceva Sante Animale Anwendung von Selegilin in Tiermedizin
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
DE4428444A1 (de) * 1994-08-11 1996-02-15 Dresden Arzneimittel Verwendung von Selegilin zur Behandlung von epileptischen Erkrankungen
CA2223588C (en) * 1995-06-07 2004-01-06 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
CA2236368C (en) * 1995-11-06 2001-10-23 Somerset Pharmaceuticals, Inc. Sublingual and buccal administration of selegiline
JP2002513383A (ja) 1997-05-21 2002-05-08 スローン−ケタリング・インスティテュート・フォー・キャンサー・リサーチ 患者の脳組織でのアスコルビン酸の濃度を増加させる方法
US6262111B1 (en) * 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US8058442B2 (en) * 2002-11-07 2011-11-15 Technion Research And Development Foundation Ltd. Neuroprotective iron chelators and pharmaceutical compositions comprising them
EP2433626B1 (de) 2003-11-25 2015-11-04 Technion Research & Development Foundation Ltd. Zusammensetzungen und Verfahren zur Behandlung kardiovaskulärer Erkrankungen
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
US8263655B2 (en) * 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
US9943489B2 (en) 2010-02-03 2018-04-17 Pharmatwob Ltd. Extended release formulations of rasagiline and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects

Also Published As

Publication number Publication date
GR3018657T3 (en) 1996-04-30
EP0562705B1 (de) 1995-10-11
ES2082587T3 (es) 1996-03-16
US5192808A (en) 1993-03-09
DK0562705T3 (da) 1996-02-19
DE69300608T2 (de) 1996-06-05
EP0562705A1 (de) 1993-09-29
DE69300608D1 (de) 1995-11-16

Similar Documents

Publication Publication Date Title
DE69300608D1 (de) Verwendung von L-Deprenyl zur Herstellung eines Arzneimittels zur Behandlung der Cushing's-Krankheit.
ATE271874T1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
DE69636085D1 (de) Verwendung von gamma-Linolensäure oder Dihomogammalinolensäure zur Herstellung eines Medikaments zur Behandlung von Huntington's Chorea
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE68905205D1 (de) Verwendung von igf-i zur herstellung eines praeparats fuer die behandlung und die verhuetung von nebeneffekten von hyperinsulinemia bei diabetikern behandelt mit insulin.
ATE164067T1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
ATE220556T1 (de) Die verwendung von lactoperoxidase, einem peroxiddonor und thiocyanat zur herstellung eines medikaments zur behandlung einer infektion mit helicobacter pylori
NL300140I1 (nl) Galanthamine, of verbindingen die eraan analoog zijn, voor behandeling van de ziekte van Alzheimer.
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
LTIP919A (en) Drugs and process for preparing thereof
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
ATE213411T1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
ATE181501T1 (de) Verwendung von l-deprenyl zur hemmung des alterniedergangs des immunsystems in säugetieren
EP0308197A3 (de) Verfahren zur Stimulierung des Immunsystems
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
DE69331546D1 (de) Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen
DE3768150D1 (de) Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
ES2110550T3 (es) Tratamiento de la carne o del pescado.
DE59304087D1 (de) Placentaextrakt und Verfahren zu seiner Herstellung
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
US5547995B1 (en) Use of selegiline in veterinary medicine
DE69424415D1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
ATE173629T1 (de) Hamamelis-trockenextrakt, verfahren zu seiner herstellung und seine verwendung als arzneimittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee